Billion

<ul class="list-ic vertical"> 
 <li> 1 <a>The American pharma company posted Q2 2023 earnings on August 1, 2023.&nbsp;</a> </li> 
 <li> 2 <a>Pfizer lost over 50% of its revenue in the yearly time frame.&nbsp;</a> </li> 
 <li> 3 <a>PFE stock price is suffering a great deal given the company performance which fell over 30% YTD.&nbsp;</a> </li> 
</ul> 
The COVID-19 pandemic put brakes on the growth of companies across industries worldwide. However, the pharmaceutical sector, especially those indulged in manufacturing vaccines to counter the virus, continued the growth. The American biopharmaceutical company, Pfizer Inc. (NYSE: PFE) was among the first companies to introduce a successful antidote. This made the company billions of dollars in sales and PFE stock price to attain its highest trading levels.&nbsp; 
However, with the world going back to normalcy again, the other businesses are picking up a gradual pace, and the COVID-19 vaccine-given charm to Pfizer is eroding.&nbsp; 
Recently the New York-headquartered company reported second-quarter earnings results on August 1st, 2023. The drop in revenue and income of the <a href="https://www.thecoinrepublic.com/2023/04/05/moderna-inc-mrna-stock-will-pharma-stocks-see-covid-like-hike/" rel="noopener noreferrer nofollow">pharma company</a> missed the estimates by slight margins but marked huge year-over-year declines. Though the PFE stock price was in declining motion already, the negative earnings pushed the price down.&nbsp; 
Pfizer posted $12.73 Billion in revenue for the quarter ended in June 2023. This marks the subsequent drop of over 30% from $18.28 Billion last quarter and 54% from the revenue of $27.7 Billion a year ago.&nbsp; 
The earnings per share (EPS) remained at $0.67 marking a 67% decline in a yearly time frame. The net income for Q2 2023 was $2.33 Billion after falling over 75% from $9.9 Billion in Q2 2022.&nbsp;&nbsp; 
Meanwhile, prominent financial institutions made adjustments in the stock rating and price target for PFE stock price. Morgan Stanely decreased the price target from $42 to $40 keeping the ‘equalweight’ rating.&nbsp; 
PFE stock price target from Goldman Sachs dropped from $58 to $54 and maintained the ‘buy’ rating. JPMorgan set the price to $39 from $41 keeping a ‘neutral’ rating.&nbsp; 
<h2 class="wp-block-heading" id="strong-pfe-stock-price-movement-strong">PFE Stock Price Movement&nbsp;</h2> 
Pfizer stock price is trading at $35 following the intraday trading session on Friday, 4th August 2023. Last week, PFE stock price dropped by 5% after posting declining earnings.&nbsp; 
The stock price is in a downfall since the start of this year and it continued to create lower lows. PFE stock is at multi-year lows at the current price after losing over 30% year-to-date.&nbsp; 
<div class="wp-block-image"> 
 <figure class="aligncenter"> 
 <img decoding="async" src="https://lh3.googleusercontent.com/CeFUoofXG1Kriuq2jyoZcB8CT_ivJaYXnN8mELUnFuWQMF5FL1xr0iB4U6lch8M11q7MLUtQwUoUCBI0uM8P5FY7qOmQrSy_fCzOYeqAfWJg05fru528KeVfcI9yF-_aw8-Ar2Q4saJnQK-w5br3xg" alt="Pfizer NYSE: PFE Stock Price Continues Decline Following Earnings"> 
 <figcaption class="wp-element-caption">
 Source: Pfizer Inc (NYSE: PFE) Stock Price Movement on <a href="https://www.tradingview.com/x/TNbRbC4U/" rel="noopener noreferrer nofollow">TradingView</a>&nbsp; 
 </figcaption> 
 </figure> 
</div> 
Pfizer stock price is below 50 and 200-day moving averages which witnessed a death crossover in February this year. Following the instance, the price took a heavy downturn and the gap between the moving averages getting broader.&nbsp; 
MACD for PFE stock is below the zero line, hardly showcasing any indication of any uptick in the recent future. RSI is at 33 and its further movement is likely to take a downside turn.&nbsp; 
<h4 class="wp-block-heading">Disclaimer</h4> 
The views and opinions stated by the author, or any people named in this article, are for informational purposes only and do not establish financial, investment, or other advice. Investing in or trading crypto assets comes with a risk of financial loss.

Pfizer NYSE: PFE Stock Price Continues Decline Following Earnings

Table of Contents

Thecoinrepublic.com

Other articles published on Aug 7, 2023

Chancer’s DeFi Platform Listed on BitMart Exchange!

Unusually High SHIB Tokens Set Ablaze Despite Anemic Price Outlook

The Ultimate PlayDapp Revolution: Elevate Your Experience with Mikey Token Staking

PayPal Makes A Game-Changing Leap Into Crypto, Launches PYUSD Stablecoin Powered by Paxos Trust

Curve Finance Recovers 73% of Stolen Funds Following Recent Hack

Kenyan police reportedly seize Worldcoin machines in warehouse raid

Join our free newsletter for daily crypto updates!